Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer
type: MedicalStudy
description: Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With RAS-mutated Metastatic Colorectal Cancer: a Dose-escalation, Phase I/II Trial
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1,PHASE2
start date: 2019-05-14
end date: 2024-11-30
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03828799
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
study subject: Metastatic Colorectal Cancer
keywords: PHASE1,PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Metastatic Colorectal Cancer

AI Analytics
type: Organization